NVIDIA, Roche, and Lam Research lead this week's top Zacks research picks, while Tredegar and Kewaunee Scientific highlight ...

(Nasdaq: EXEL) today announced results from a subgroup analysis of the CABINET phase 3 pivotal trial evaluating CABOMETYX ® (cabozantinib) versus placebo in patients with previously treated advanced ...

Bitcoin's MVRV bands indicate that the coin remains in a mid-cycle growth phase. $3.2 billion stablecoin inflows hint at ...

We initiated eight new positions in the quarter, highlighted by the addition of two leading biotechnology companies and ...

Q3 2025 marked a strong recovery for Kingdom Capital Advisors, with September 30th ranking among the best single-day ...

NVIDIA, Roche, and Lam Research lead today's top Zacks reports, showcasing standout growth drivers and sector-specific strengths.

Bitcoin Cash price rebounds above $540 after the weekend crash. Active addresses surge to 7.28 million, reflecting a rise in ...

Sage Therapeutics has agreed to be acquired by Supernus Pharma in a deal valued at around $571 million, bringing together two companies working on central nervous system therapies that have suffered ...

You don’t have to be a CEO, baby, to be in our show. The executives are great, but Arkansas Money & Politics readers ...

Following a costly first-quarter fumble from redshirt senior tight end Lake McRee and an improvement in Wolverine freshman ...